BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31421101)

  • 21. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
    Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery for young patients with lung cancer.
    Tian DL; Liu HX; Zhang L; Yin HN; Hu YX; Zhao HR; Chen DY; Han LB; Li Y; Li HW
    Lung Cancer; 2003 Nov; 42(2):215-20. PubMed ID: 14568689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of bronchial and pharyngo-laryngeal malignancies. A reappraisal.
    Massard G; Wihlm JM; Ameur S; Jung GM; Rougé C; Dumont P; Roeslin N; Morand G
    Eur J Cardiothorac Surg; 1996; 10(6):397-402. PubMed ID: 8817132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival in patients with metachronous second primary lung cancer.
    Ha D; Choi H; Chevalier C; Zell K; Wang XF; Mazzone PJ
    Ann Am Thorac Soc; 2015 Jan; 12(1):79-84. PubMed ID: 25494009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.
    Lin Q; Sun X; Zhou N; Wang Z; Xu Y; Wang Y
    BMC Pulm Med; 2019 May; 19(1):98. PubMed ID: 31118007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
    Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
    Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical Outcomes of Non-small Cell Lung Cancer in Patients with a History of Pancreaticobiliary Cancer.
    Tagawa T; Ito K; Fukuzawa K; Okamoto T; Fujinaga A; Kawasaki T; Masuda T; Iwaki K; Terashi T; Okamoto M; Shiromizu A; Motohiro A; Maehara Y
    Anticancer Res; 2017 Jun; 37(6):3307-3309. PubMed ID: 28551682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage I non-small cell lung carcinoma: really an early stage?
    Rena O; Oliaro A; Cavallo A; Filosso PL; Donati G; Di Marzio P; Maggi G; Ruffini E
    Eur J Cardiothorac Surg; 2002 Mar; 21(3):514-9. PubMed ID: 11888773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis associated with synchronous or metachronous multiple primary malignancies in patients with completely resected non-small cell lung cancer.
    Komatsu H; Izumi N; Tsukioka T; Inoue H; Hara K; Miyamoto H; Nishiyama N
    Surg Today; 2019 Apr; 49(4):343-349. PubMed ID: 30417262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.
    Thorsteinsson H; Alexandersson A; Oskarsdottir GN; Skuladottir R; Isaksson HJ; Jonsson S; Gudbjartsson T
    J Thorac Oncol; 2012 Jul; 7(7):1164-9. PubMed ID: 22592213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better?
    Subramanian M; Liu J; Greenberg C; Schumacher J; Chang GJ; McMurry TL; Francescatti AB; Semenkovich TR; Hudson JL; Meyers BF; Puri V; Kozower BD
    J Thorac Cardiovasc Surg; 2019 Mar; 157(3):1205-1217.e2. PubMed ID: 31130741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
    Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
    J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNM stage is the most important determinant of survival in metachronous lung cancer.
    Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
    Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor.
    Lyons G; Quadrelli S; Silva C; Vera K; Iotti A; Venditti J; Chertcoff J; Chimondeguy D
    J Thorac Oncol; 2008 Sep; 3(9):989-93. PubMed ID: 18758301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A propensity score matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma.
    Zhang Y; Sun Y; Chen H
    Oncotarget; 2016 Mar; 7(12):13880-5. PubMed ID: 26871600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
    Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
    Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses.
    Suzuki K; Nagai K; Yoshida J; Nishimura M; Takahashi K; Yokose T; Nishiwaki Y
    Cancer; 1999 Nov; 86(10):1976-84. PubMed ID: 10570421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of multiple previous malignancies should not be a contraindication to the surgical resection of lung cancer.
    Pagès PB; Mordant P; Grand B; Badia A; Foucault C; Dujon A; Le Pimpec-Barthes F; Riquet M
    Ann Thorac Surg; 2013 Mar; 95(3):1000-5. PubMed ID: 23375734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis.
    Mokhles S; Verstegen N; Maat AP; Birim Ö; Bogers AJ; Mokhles MM; Lagerwaard FJ; Senan S; Takkenberg JJ
    Lung Cancer; 2015 Mar; 87(3):283-9. PubMed ID: 25622781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.